The cross link below discusses the use of neural stem cells to track and carry chemotherapeutic drugs or antibodies to cells that migrate away from a brain tumor.
Keith Black, M.D. (Cedars-Sinai in Los Angeles), is cited in the article. As some of you may know, Dr. Black is on the HER-2 Support Group Board of Advisors, and is one of the world's preeminent neurosurgeons.